2023
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis
View Article
External Publications
Curated external research publications relevant to understanding and treating rheumatic immune-related adverse events from cancer immunotherapy.
8 publications
Filter by type
2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
View Article
2022
Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor- induced activation of intermediate monocytes in synovial fuid mononuclear cells from patients with infammatory arthritis
View Article
2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease
View Article
2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease
View Article
2021
TNF in the era of immune checkpoint inhibitors: friend or foe?
View Article
2021
Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer
View Article
2020
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
View Article